Background 50 Several observational studies suggest that variations in thyroid function, even within the normal 51 range, are a risk factor for cardiovascular diseases, but it remains to be determined if these 52 associations are causal or not. This study investigates whether the relationship between variation 53 in normal range thyroid function, as well as hypothyroidism and hyperthyroidism, and the risk of 54 stroke and Coronary Artery Disease (CAD) are causal and via which pathways these relations are 55 mediated.
Introduction 72
Despite the undeniable progress in prevention and treatment in the past two decades, 73 cardiovascular disorders (CVD) remain the leading cause of mortality worldwide (1). Whereas 74 smoking, hypertension, diabetes, obesity and dyslipidaemia are the major modifiable 75 cardiovascular risk factors (2), observational studies have demonstrated that also overt and 76 subclinical thyroid dysfunction are associated with a higher risk of CVD(3-6). Moreover, even 77 variation in thyroid function within the normal range has been associated with an increased risk 78 of CVD, including atherosclerotic disease and stroke (7) (8) (9) (10) . This poses the question as to whether 79 common forms of mild thyroid dysfunction (with a prevalence of 5-10 % in the general population) 80 should be treated to prevent these complications. Unfortunately, no data on the effects of treatment 81 of these milder forms of thyroid dysfunction on cardiovascular mortality or morbidity are available 82 from well-powered randomized controlled trials (RCTs) (11, 12) . Moreover, given the follow-up 83 time and sample sizes required for such conclusive RCTs, these data will not become available in 84 the next few years (if ever). Mendelian randomization (MR) is another approach that can provide 85 crucial information on causality when RCTs are not feasible or unavailable (13) . MR evaluates 86 the effect of an exposure (e.g. thyroid function) on an outcome (e.g. CVD) using genetic variants 87 associated with the exposure as instruments (14) . MR draws from the fact that genetic variants 88 segregate randomly from parents to offspring, which is comparable to the randomization used in 89 clinical trials. As 65% of the total variance in TSH and FT4 levels is determined by genetic factors 90 (15), there are good grounds for MR studies on thyroid function and various outcomes. Evidence 91 from a previous MR study suggests no causal association between thyroid traits (TSH, FT4) and 92 ischemic heart disease(16). However, this study had only limited power due to the small number 93 of genetic variants (variance explained: 5.6% for TSH and 2.3% for FT4) used as instruments (17) . 94 Recently, the ThyroidOmics consortium reported the largest meta-analysis of genome-wide 95 association studies (GWAS) on thyroid function in over 72,000 subjects which more than doubled 96 the number of loci associated with thyroid function (18). These findings paved the way to conduct 97 well-powered MR studies to test the causality of the observed associations between thyroid 98 function and CVD. To this end, we performed two-sample MR to investigate the role of thyroid 99 function on CAD and stroke respectively using as instrument the variants reported from the above 100 GWAS on thyroid function and publicly available summary statistics from the two largest GWAS 101 on CAD(19) and stroke (19, 20) . Next to normal range thyroid function, MR studies on subclinical 102 and overt thyroid disease, including Hashimoto's disease (HD) and Graves' disease (GD), are 103 presented as secondary analyses, thereby covering the entire spectrum of thyroid (dys) function.
104
Finally, mediation analyses were performed to investigate the pathophysiological mechanisms 105 underlying the causal associations. 
Two-sample Mendelian Randomization

109
We performed two-sample MR analysis by using summary genetic data from the largest GWAS 110 studies available for thyroid function (18), CAD(19) and stroke (20) . The exposures of interest 111 included: normal range TSH and FT4 levels, GD and HD. As subclinical hypo-and 112 hyperthyroidism have been associated with CAD and stroke, we additionally investigated 113 increased TSH and decreased TSH levels, respectively. Summary data of the variants identified to 114 be associated with the exposure were extracted. CAD data were derived from the largest 115 systematic GWAS meta-analysis, involving 122,733 CAD cases and 424,528 controls from the 116 van Harst el al (19) . Stroke data were derived from the recent multi-ethnic meta-analysis for any 117 stroke, provided by the MEGASTROKE consortium (20).
118
The two-sample MR was performed using the Inverse Variance Weighted (IVW)(21) method 119 (assuming that all the IV assumptions are met). We also used other methods relaxing the third 120 assumption about pleiotropy (MR-Egger (Egger)(22); Weighted Median (WM) (23)). An IVW 121 corrected for the SEs of each instrument, for the correlation between the associations of the 122 instrument with the exposure and the association of the instrument with the outcome was also 123 used. Heterogeneity for the Wald ratios was tested with the Cochran's Q and quantified with the 124 I 2 index (24). The strength of the association between the exposure and the outcome was estimated 125 by calculation of the F-statistic (25).
126
In order to quantify the strength of the "NO Measurement Error" assumption (NOME) for MR-
127
Egger we used the I 2 statistic of the genetic association estimates on the exposures. This measure 128 is called I 2 GX and lies between 0 and 1. A high value of I 2 GX (close to 1) indicates that dilution bias 129 does not affect the standard MR-Egger analyses performed (24). In the main analyses we used the 130 first order weights, which correspond to the first term of the Taylor series expansion, which 131 approximate the SE of the Wald ratio estimate (24). The IVW and the MR-Egger regression 132 analyses were repeated using the second order weights, which correspond to the first two terms of 133 the Taylor series expansion (24). 134 We also applied other MR methods relaxing the InSIDE (Instrument Strength Independent of Genetic variants used as instruments 147 We used 55 and 29 single nucleotide polymorphisms (SNPs) associated at a genome-wide 148 significant level (p<5e-8) with TSH and FT4 levels within the reference range, respectively, as 149 instruments to investigate the causal role of minor variation in thyroid hormones levels on CAD 150 and any stroke.
151
In order to cover the entire spectrum of thyroid (dys)function, for secondary analyses we assessed 152 the causal effect of mild thyroid dysfunction on these two outcomes by using variants and 153 summary data derived from two separate case-control GWAS meta-analyses of increased TSH 154 levels (i.e., (subclinical and overt) hypothyroidism) and decreased TSH levels (i.e., (subclinical 155 and overt) hyperthyroidism), including cases with TSH levels above and below the cohort-specific 156 reference range, respectively, and controls with TSH levels within the reference range(18). One 157 condition of MR is that exposure-related SNPs (the instrumental variables) must not be in Linkage 
162
We also performed a literature search for HD (20 variants) and GD (49 variants) associated 163 variants to assess the causal role of thyroid disease on CAD and stroke. The summary statistics 164 for these variants and their association with the corresponding thyroid disease were derived from 165 UK Biobank. The UK Biobank (UKBB) study recruited more than 500,000 individuals across Great Britain 169 from 2006-2010(32)(http://biobank.ctsu.ox.ac.uk).
170
ICD10 codes used to define HD were E03.8, E03.9 and E06.3. For GD these were E05.0, E05.8, 171 E05.9. Summary statistics for TSH, FT4, increased and decreased TSH associated variants were extracted 175 from the currently largest GWAS meta-analysis for thyroid function (18). For HD and GD risk 176 variants we used summary associations derived from UKBB, as described above. CAD data were 177 extracted from the most recent meta-analysis that used data from the Harst el al. meta-analysis (19) 
Results
246
Normal range TSH and FT4 levels 247 MR analyses indicated a significant causal association between higher TSH levels within the 248 reference range and a lower risk of stroke (OR=0.95, 95% CI= 0.91-0.99, p =0.008 per 1 SD 249 increase in TSH levels). There was no evidence of directional pleiotropy (Egger intercept= 1.06e-250 5, SE= 0.003) ( Fig 1A) . Next to the IVW method, we applied additional MR approaches (see 251 methods), as no single method controls for all statistical properties that may impact MR estimates.
252
The GSMR and MR PRESSO analyses yielded similar results to IVM (STable14 A, B) , further 253 corroborating the causal association between higher TSH levels and a lower risk of stroke. The
254
WM approach yielded marginally significant results, but thedirection and magnitude of the effect 255 was the same as observed in the other methods (OR=0.95, 95% CI= 0.92 to 0.98, p =0.092)
256
(STable 1).
257
There was no evidence for a causal association between normal range FT4 levels and the risk of 258 stroke (IVW: OR=0.97, 95% CI= 0.89-1.06, p =0.502 per 1 SD increase in FT4 levels) (STable 259 2, Fig 1A) ).
260
For CAD, no causal associations were detected with normal range TSH (OR=1.01, 95% CI= 0.96 261 to 1.05, p =0.8 per 1SD increase in TSH levels) or FT4 levels (OR=0.99, 95% CI= 0.94 to 1.04, p 262 =0.66 per 1SD in FT4 levels) using IVW (STables 3 -4). Similar results were obtained with the 263 other methods (Stables 3-4, Fig 1B) . Egger regression did not provide any evidence for directional 264 pleiotropy (TSH: Intercept= 0.003, 95% CI= -0.004 to 0.010, FT4: Intercept= -0.005, 95% CI= -265 0.014 to 0.003). As the results presented above suggested that AF was a putative mediator for the effect of TSH 323 levels on stroke risk, we used the MR-BMA method to further corroborate this finding. MR-BMA 324 can detect true causal risk factors even when the candidate risk factors are highly correlated. This 325 analysis also showed that AF was the top mediating factor (STable 12; SFig 1). Further inspection 326 of the models indicated two variants (rs74804879, rs17477923) as influential points. MR-BMA 327 analysis after excluding these two variants showed again AF as the top risk factor (STable 13).
329
Multivariable MR analyses were also performed for the observed causal association between HD 330 and CAD to detect potential mediators. These analyses indicate that the effect of HD on CAD may 331 be mediated via BMI (STable 10B; Fig 3) . In this study, we undertook the largest two-sample MR analyses of thyroid function (TSH and FT4 346 levels) on CAD and stroke risk. Our results show that higher TSH levels within the normal range 347 are associated with lower the risk of stroke, and that this effect is likely mediated by a lower risk 348 of AF. Furthermore, we find a causal association between HD and CAD.
350
Higher normal range TSH levels lower the risk of stroke via a lower risk of atrial fibrillation 351
Ischemic stroke is the most common type of stroke, responsible for approximately 80% of all 352 stroke incidents(41). Several modifiable cardiovascular risk factors for ischemic stroke have been 353 identified, including hypertension, T2D, dyslipidaemia, obesity and AF(42). Observational studies 354 showed that even variation in thyroid function within the normal range is associated with these 355 factors(43), suggesting that minor variation in thyroid function might be a potential risk factor for 356 stroke.
357
In 2016, a multi-center study including 43,598 participants investigated the association between 358 variation in normal range thyroid function and stroke risk (9). This study showed that higher TSH 359 levels within the normal range were associated with a decreased risk of stroke, while higher FT4 360 levels within the normal range were associated with an increased risk of stroke. These effects were 361 independent from traditional cardiovascular risk factors including SBP, TC levels, smoking status 362 and T2D (9).
363
In our study, we investigated whether causal relationships underlie these epidemiological 364 observations. We demonstrate that higher TSH levels within the reference range are causally 365 associated with a decreased risk of stroke, which is mediated by the decreased risk of AF. This is 366 in line with the results of observational studies which have shown that AF is a major risk factor 367 for stroke, increasing stroke risk up to five-fold (44). Our findings are also in line with recent 368 studies showing that subjects with a genetically predicted higher TSH level have a lower risk of 369 AF (40). While multiple pathophysiological pathways might be theoretically involved in the effect 370 of thyroid function on stroke, we demonstrated that AF has a major role in mediating the effect of 371 TSH within the reference range on the stroke risk.
372
However, we did not observe a causal effect of FT4 levels on the risk of stroke. This may be 373 because genetic variants used as instruments in our study could explain less variance in FT4 than 374 in TSH levels (i.e. 9.4% and 4.8% of the genetic variance in TSH and FT4 levels, respectively)(18) 375 and therefore our study was better powered to detect the causal effect on the stroke risk for TSH.
376
This suggests that the causal effect of minor variation in FT4 levels on the stroke risk is smaller 377 than detectable in our study. the CAD risk only, and did not find an association (8, (45) (46) (47) TSH levels and stroke, we also investigated potential mediators of this effect and proved that this 420 effect is mediated via AF.
421
Given the relatively large number of variants with unclear physiological function included in the 422 MR analyses, it is possible that some of them may still confer pleiotropic effects. However, using 423 multiple variants associated with TSH and FT4 levels should significantly reduce the impact of 424 individual SNPs associated with the outcome through alternative pathways (14).
425
Furthermore, a higher number of variants are included as instruments, which explain a higher 426 portion of variance in FT4 and TSH levels (i.e. 9.4% and 4.8% of the genetic variance in TSH and 427 FT4 levels, respectively) (18).
428
Finally, the IVW method can lead to moderately biased estimates for binary outcomes(51). To 429 address this issue, we applied different MR approaches, which led to consistent results.
431
Conclusions 432 We demonstrate that higher TSH levels within the normal range is associated with a lower the risk 433 of stroke, which is mediated by a decreased risk of AF. These results introduce minor variation in 434 normal range thyroid function as a novel modifiable risk factor for stroke. Additionally, we show 435 that the HD effect on CAD is mediated via BMI. This is important as thyroid dysfunction affects 436 5-10% of the general population, and these results pave the way to consider future adjustment of 437 thyroid function within the normal range in managing patients' risk of stroke. These findings also 438 have clinical implications as they pave the way to consider future adjustment of thyroid function 439 within the normal range in managing patients' risk of stroke. 
